bcl-2 and p53 gene products have been both linked to programmed cell death pathways. We have analyzed several human breast cancer cell lines for the expression of bcl-2 and p53. We found an inverse correlation between the expression of the two proteins. The result suggested that mutant p53 could substitute for bcl-2 function in breast cancer cells and that could also down-regulate bcl-2 expression. We found, indeed, that overexpression of a mutant p53 (mut 175) in MCF-7 cells could induce down-regulation of bcl-2 both at protein and mRNA level. However, the promoter region of the human bcl-2 gene does not contain the negative regulatory element responsible for the down-regulation. If this mechanism will be proved also for the wild-type p53 ...
Apoptosis, a normal physiological form of cell death, is critically involved in the regulation of ce...
With the ultimate goal of characterizing the molecular pathogenesis of oral cancer, the most predomi...
Preoperative chemotherapy administered to breast cancer (BC) patients is a model for studying in viv...
In the present studies, the mechanisms of estrogen regulation of Bcl-2 were investigated by analyzin...
Tissue homeostasis and the maintenance of cell populations depend on a delicate balance between the ...
Bax and Bcl-2 are proteins that regulate programmed cell death and apoptosis. The expression of thes...
Alterations in the mechanisms of apoptosis are responsible not only for the progression of breast ca...
Bcl-2 is an anti-apoptotic protein belonging to a family of proteins that act as regulators of apopt...
Programmed cell death is an important determinant of the response to chemotherapy. Among the factors...
Breast cancer amplified sequence 2 (BCAS2) was reported previously as a transcriptional coactivator ...
The p53 tumor suppressor protein can induce both apoptosis and cell cycle arrest. Moreover, we and o...
In this study, the expression of p53 (wild-type and mutated form) and bcl-2 in ductal carcinoma in s...
AbstractThe bcl-2 gene is an important antagonist of apoptosis, the programmed cell death. Bcl-2 is ...
The Bcl-2 pro-survival protein is an important regulator of apoptosis and has been implicated in me...
Follicular lymphoma is the most common lymphoid malignancy in humans. The bcl-2 transgenic mice, whi...
Apoptosis, a normal physiological form of cell death, is critically involved in the regulation of ce...
With the ultimate goal of characterizing the molecular pathogenesis of oral cancer, the most predomi...
Preoperative chemotherapy administered to breast cancer (BC) patients is a model for studying in viv...
In the present studies, the mechanisms of estrogen regulation of Bcl-2 were investigated by analyzin...
Tissue homeostasis and the maintenance of cell populations depend on a delicate balance between the ...
Bax and Bcl-2 are proteins that regulate programmed cell death and apoptosis. The expression of thes...
Alterations in the mechanisms of apoptosis are responsible not only for the progression of breast ca...
Bcl-2 is an anti-apoptotic protein belonging to a family of proteins that act as regulators of apopt...
Programmed cell death is an important determinant of the response to chemotherapy. Among the factors...
Breast cancer amplified sequence 2 (BCAS2) was reported previously as a transcriptional coactivator ...
The p53 tumor suppressor protein can induce both apoptosis and cell cycle arrest. Moreover, we and o...
In this study, the expression of p53 (wild-type and mutated form) and bcl-2 in ductal carcinoma in s...
AbstractThe bcl-2 gene is an important antagonist of apoptosis, the programmed cell death. Bcl-2 is ...
The Bcl-2 pro-survival protein is an important regulator of apoptosis and has been implicated in me...
Follicular lymphoma is the most common lymphoid malignancy in humans. The bcl-2 transgenic mice, whi...
Apoptosis, a normal physiological form of cell death, is critically involved in the regulation of ce...
With the ultimate goal of characterizing the molecular pathogenesis of oral cancer, the most predomi...
Preoperative chemotherapy administered to breast cancer (BC) patients is a model for studying in viv...